S. Kishino et al., CHANGES IN THE BINDING-CAPACITY OF ALPHA-1-ACID GLYCOPROTEIN IN PATIENTS WITH RENAL-INSUFFICIENCY, Therapeutic drug monitoring, 17(5), 1995, pp. 449-453
The elevation of alpha-1-acid glycoprotein (AAG) concentration and the
binding characteristics of disopyramide (DP) to AAG in patients with
renal insufficiency were investigated. The serum AAG concentration and
protein binding of DP in patients were significantly greater than tho
se in healthy subjects. However, in both the serum and the purified AA
G, Scatchard analysis showed that the number of binding sites per mole
cule of AAG in patients was significantly lower than that in healthy s
ubjects, although there was no difference in the dissociation constant
(K-d). These results suggest that the AAG induced in renal insufficie
ncy is qualitatively different from normal AAG. Moreover, the change o
f the unbound DP fraction when DP concentration was increased was larg
er in the patients than in the healthy controls. Therefore, monitoring
of the unbound DP would be important for therapeutic drug monitoring
in patients with renal insufficiency.